Slide 1: ESG briefing
ESG briefing March 24, 2020 /48
Slide 2: Today's program
Today's program 1. Corporate philosophy and sustainability 2. Corporate governance 3. Medium- and long-term environmental vision and management 4. Creating social value 1/48
Slide 3: Corporate Philosophy
Corporate Philosophy Our Vision is to strive with the utmost effort and strong determination to meet the challenge of combining our individual competencies to deliver new, innovative drugs to patients. We will continue being the most passionate champion in the fight against disease and pain, togethe
Slide 4: For Growth of the Company
For Growth of the Company 3/48
Slide 5: Materiality Analysis
Extremely high importance Implementation of responsible Creation of innovative drugs @ Organize CSR Issues marketing and promotion activiti a aoe of product reliability in the Business Activities Provision of a stable supply AUN EELEL : of high-c 1-quality, easy-to easy-to-use products | @ Intellect
Slide 6: Materiality Map (important items excerpt)
Materiality Map (important items excerpt) 5/48
Slide 7: Relevant Sustainable Development Goals (SDGs)
Relevant Sustainable Development Goals (SDGs) Materiality Relevant Goals 6/48
Slide 8: Our Contribution to the SDGs
Our Contribution to the SDGs 7/48
Slide 9: External ESG Evaluation
External ESG Evaluation Evaluation FY2017 FY2018 FY2019 Climate Change:A- Climate Change:A Climate Change: A CDP Water:B Water:B Water: A- Selected Selected FTSE Score:2.8/5.0 Score:3.2/5.0 Score:3.4/5.0 Selected MSCI Score:BBB Score:BBB Score:A DJSI Score:16/100 Score:19/100 Score:60/100 Toyo Keiza
Slide 10: ESG-related Awards
ESG-related Awards ESG Finance Awards Japan in FY2019 Environment Minister's Award for Global Warming Prevention Activity in the "Implementation and Dissemination of Countermeasures" Category in FY2019 Osaka Stop Global Warmings Award in FY2018 9/48
Slide 11: CSR Promotion Structure
CSR Promotion Structure 10/48
Slide 12: Today's program
Today's program 1. Corporate philosophy and sustainability 2. Corporate governance 3. Medium- and long-term environmental vision and management 4. Creating social value 11/48
Slide 13: G: Corporate Governance Structure
G: Corporate Governance Structure 12/48
Slide 14: G: Efforts to Enhance Governance
G: Efforts to Enhance Governance 2011 2013 2014 2015 2016 2017 2018 2019 "Dedicated to man's fight against disease and pain" Corporate philosophy ● Conceptual framework of mission established Separation of ● Executive officer system introduction ● Scope of authority delegated to management (Manageme
Slide 15: G: Outside Directors (Independent Executives)
G: Outside Directors (Independent Executives) Three out of 8 directors are outside directors with the aim of strengthening the oversight function of the Board of Directors, maintaining and improving management transparency and the accuracy of business execution. Yutaka Kato Jun Kurihara Masao Nomura
Slide 16: G: Officer Personnel Affairs and Remuneration Committees
G: Officer Personnel Affairs and Remuneration Committees Two committees led by highly independent outside directors as key members ensure management transparency and objectivity by discussing officer personnel affairs and officer remuneration, both of which have governance-related importance. Intern
Slide 17: G: Directors' Remuneration
G: Directors' Remuneration Directors (not including outside directors) Set by referencing executive compensation databases Fixed remuneration and accounting for business size of the company, (about 70%) position, etc. ＋ Sound incentives aimed at ensuring sustainable growth Performance-linked ⇒ achie
Slide 18: G: Evaluations of Board of Directors' Effectiveness
G: Evaluations of Board of Directors’ Effectiveness Effectiveness of the board of directors annually by all of the directors and company auditors Self-evaluation conducted using questionnaires and interviews, results of which are used to improve the board Questionnaires Questions highlighting Contri
Slide 19: G: Cross-shareholdings
G: Cross-shareholdings About 30% reduction planned for cross-shareholdings from the level at end of March 2018 (111 issues totalling 167.1 billion yen) over the next three years starting from November 2018, aiming to improve capital efficiency and keep pace with changing environment surrounding corp
Slide 20: G: Company-wide Risk Management
G: Company-wide Risk Management 19/48
Slide 21: G: Issues Going Forward
G: Issues Going Forward 20/48
Slide 22: Today's program
Today's program 1. Corporate philosophy and sustainability 2. Corporate governance 3. Medium- and long-term environmental vision and management 4. Creating social value 21/48
Slide 23: E: Environmental VISION (FY2019~)
E:Environmental VISION（FY2019~） 22/48
Slide 24: E: Promotion of Environmental Management
E:Promotion of Environmental Management Status of acquisition of ISO 14001 certification Production site name First acquired in Fujiyama Plant November 2002 Joto Plant February 2004 ISO 14001 acquisition percentage for 100% production sites *Production sites in operation are 100% ISO14001 certified.
Slide 25: E: Science Based Targets (SBT) Approval
E:Science Based Targets (SBT) Approval ・Our mid- to long-term greenhouse gas reduction targets are approved by SBT as having a scientific basis. ・Our goal is categorized as the highest goal, “1.5 ℃”. 24/48
Slide 26: E: Emission reduction activities
E:Emission reduction activities 25/48
Slide 27: E: Reducing Environmental Impact of Products
E: Reducing Environmental Impact of Products 26/48
Slide 28: E: Policy Direction Going Forward
E: Policy Direction Going Forward Measures to address recommendations by Task Force on Climate-related Financial Disclosures (TCFD) ・ We expressed endorsement in October 2019 ・ We will step up measures to address the following TCFD recommendations: •Access https://www.fsb-tcfd.org/ for more informat
Slide 29: Today's program
Today's program 1. Corporate philosophy and sustainability 2. Corporate governance 3. Medium- and long-term environmental vision and management 4. Creating social value 28/48
Slide 30: S: Improving Medical Access
S:Improving Medical Access 29/48
Slide 31: S: Improving Medical Access
S:Improving Medical Access 30/48
Slide 32: S: Development of Human Resources
S:Development of Human Resources 31/48
Slide 33: S: Development of Human Resources
S:Development of Human Resources 【Training for selected employees】 Objective：Foster awareness and autonomy as management Major training curriculum（For executives） ※Management discussions including exchanges with other companies' executive classes ●Future vision ●View of management ●Decision making M
Slide 34: S: Goal of Work-style Reforms and Health and Productivity Management
S: Goal of Work-style Reforms and Health and Productivity Management 33/48
Slide 35: S: Conceptual Framework of Work-style Reforms from FY2015
S: Conceptual Framework of Work-style Reforms from FY2015 Conceptual diagram of Create a company that will last in the next 100 years our activity Growth of individuals Review work style Maximize Realize corporate philosophy produce and company Maximize impact of strategies value Improve operational
Slide 36: History of Efforts (Action)
History of Efforts (Action) 2015 2016 2017 2018 2019 ■President declaration ■ Employees encouraged to ■President declaration ■President declaration ■ Commendation system take paid leave ■ No-overtime days ■ Meetings visualized and ■ Encouragement of paid ■ Roles set for all introduced reduced leave
Slide 37: History of Efforts (System)
History of Efforts (System) 2015 2016 2017 2018 2019 ■ Child-care support system ■ Support for employees with ■ Membership in employee ■ Flex time system expanded ■ Commissioned rehiree brochure created cancer system ■ Scope expanded for cumulative welfare club ■ Manual for short working ■ Child-car
Slide 38: Support for Employees with Cancer (from 2017)
Support for Employees with Cancer (from 2017) We want to create an environment where employees with cancer can continue work while receiving treatment. Introduction/expansion of various systems ■ Extension of leave length ■ Payment of injuries and sickness benefits ■ Permission to take cumulative pa
Slide 39: Sharing of Achieved Value (from 2018)
Sharing of Achieved Value (from 2018) We want employees to feel results of their effort. Families with membership in To employees and welfare club can use their families it; other enhancement ～Enhanced welfare programs～ to welfare programs Decided based on suggestions by general → We want families t
Slide 40: ONO SWITCH Project (from 2018)
ONO SWITCH Project (from 2018) SWITCH: Save the World by our work style ImprovemenT and CHange Specified ratio of expected reduction A program under which a specified ratio of saved overtime-pay Paid separately by company amount is donated to nonprofit or nongovernmental organizations To society S
Slide 41: Promotion of Health Management (from Apr 2018)
Promotion of Health Management (from Apr 2018) Basic policy １．We will promote the maintenance and improvement of the health of employees and their families through the Health Up Committee, consisting of representatives from the company, labor unions, occupational health staff, and health insurance s
Slide 42: Structure to Promote Health Management
Structure to Promote Health Management Unified effort of company, labor union, health insurance society and public health nurses 41/48
Slide 43: Health Improvement Declaration (2018)
Health Improvement Declaration (2018) Our target state (president's message) We wish to contribute to society by developing innovative drugs under the corporate philosophy, "dedicated to man's fight against disease and pain." We believe that, in order for us to be able to continue to face challenges
Slide 44: Trends in Health Management Survey Results
Trends in Health Management Survey Results 43/48
Slide 45: Evaluation related with Human Resources
Evaluation related with Human Resouces Selected in 2020 Health & Productivity Stock Selected as a 2020 Certified Health & Productivity Management Outstanding Organization (White 500) for 2 consecutive years Platinum Kurumin Certified as a high-level child-rearing support company 44/48
Slide 46: S: Strengthening Supply Chains
S: Strengthening Supply Chains We need to strengthen supply chains in CSR aspects, in addition to procurement QCD. Companies Partners 45/48
Slide 47: S: Strengthening Supply Chains
S: Strengthening Supply Chains 46/48
Slide 48: S: Medical and Health
S: Medical and Health Healthy Body Campaign We started this project as a reconstruction assistance activity from Diabetes the Great East Japan Earthquake in FY2015～ 2015. Communicate & Link exhibition A panel of 150 works that have passed the first judging out of 1,000 works published on the WEB wil
Slide 49: Our Approach to ESG
|Our Approach to ESG i Setting and publishing our vision i Setting specific aims and goals @ Extraction of and response to challenges by information collection and analysis @ Internal and external collaboration im ONO PHARMACEUTICAL €O,LTD. 48/48
Slide 50: ONO PHARMACEUTICAL CO.,LTD.
ono ONO PHARMACEUTICAL CO.,LTD. Dedicated to Man’s Fight against Disease and Pain